203 related articles for article (PubMed ID: 34312470)
1. Incidence, demographics, and survival of patients with primary pituitary tumors: a SEER database study in 2004-2016.
Chen C; Hu Y; Lyu L; Yin S; Yu Y; Jiang S; Zhou P
Sci Rep; 2021 Jul; 11(1):15155. PubMed ID: 34312470
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Prognostic Factors of Patients with Benign Pituitary Tumors Based on the Surveillance, Epidemiology, and End Results (SEER) Database.
Guo X; Wu Y; Fang J
World Neurosurg; 2022 Sep; 165():e30-e42. PubMed ID: 35504480
[TBL] [Abstract][Full Text] [Related]
3. Pituitary germinomas: a multi-institutional study analyzing patient demographics and management patterns.
Bhimani AD; Barrington NM; Aguilar TM; Arnone GD; Mehta AI
Pituitary; 2020 Aug; 23(4):381-388. PubMed ID: 32388804
[TBL] [Abstract][Full Text] [Related]
4. Demographic and socioeconomic disparities of pituitary adenomas and carcinomas in the United States.
Ghaffari-Rafi A; Mehdizadeh R; Ghaffari-Rafi S; Castillo JA; Rodriguez-Beato FY; Leon-Rojas J
J Clin Neurosci; 2022 Apr; 98():96-103. PubMed ID: 35151063
[TBL] [Abstract][Full Text] [Related]
5. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
6. Treatment modalities and outcomes of granular cell tumors and spindle cell oncocytomas of the pituitary gland: an analysis of two national cancer databases.
Yohan Alexander A; Michalopoulos G; Kerezoudis P; Van Gompel JJ; Link MJ; Peris-Celda M
Acta Neurochir (Wien); 2024 Apr; 166(1):169. PubMed ID: 38578465
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality.
Nilsson B; Gustavasson-Kadaka E; Bengtsson BA; Jonsson B
J Clin Endocrinol Metab; 2000 Apr; 85(4):1420-5. PubMed ID: 10770176
[TBL] [Abstract][Full Text] [Related]
8. Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program.
Zacharia BE; Bruce SS; Goldstein H; Malone HR; Neugut AI; Bruce JN
Neuro Oncol; 2012 Aug; 14(8):1070-8. PubMed ID: 22735773
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for survival in patients with epithelioid sarcoma: 441 cases from the SEER database.
Jawad MU; Extein J; Min ES; Scully SP
Clin Orthop Relat Res; 2009 Nov; 467(11):2939-48. PubMed ID: 19224301
[TBL] [Abstract][Full Text] [Related]
10. Pituitary Adenoma Incidence, Management Trends, and Long-term Outcomes: A 30-Year Population-Based Analysis.
Graffeo CS; Yagnik KJ; Carlstrom LP; Lakomkin N; Bancos I; Davidge-Pitts C; Erickson D; Choby G; Pollock BE; Chamberlain AM; Van Gompel JJ
Mayo Clin Proc; 2022 Oct; 97(10):1861-1871. PubMed ID: 35753823
[TBL] [Abstract][Full Text] [Related]
11. Invasive adenoma and pituitary carcinoma: a SEER database analysis.
Hansen TM; Batra S; Lim M; Gallia GL; Burger PC; Salvatori R; Wand G; Quinones-Hinojosa A; Kleinberg L; Redmond KJ
Neurosurg Rev; 2014 Apr; 37(2):279-85; discussion 285-6. PubMed ID: 24526366
[TBL] [Abstract][Full Text] [Related]
12. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
13. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.
Gittleman H; Ostrom QT; Farah PD; Ondracek A; Chen Y; Wolinsky Y; Kruchko C; Singer J; Kshettry VR; Laws ER; Sloan AE; Selman WR; Barnholtz-Sloan JS
J Neurosurg; 2014 Sep; 121(3):527-35. PubMed ID: 24926650
[TBL] [Abstract][Full Text] [Related]
14. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
15. Incidence and prevalence of acromegaly in a large US health plan database.
Burton T; Le Nestour E; Neary M; Ludlam WH
Pituitary; 2016 Jun; 19(3):262-7. PubMed ID: 26792654
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study.
Agustsson TT; Baldvinsdottir T; Jonasson JG; Olafsdottir E; Steinthorsdottir V; Sigurdsson G; Thorsson AV; Carroll PV; Korbonits M; Benediktsson R
Eur J Endocrinol; 2015 Nov; 173(5):655-64. PubMed ID: 26423473
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenoma: a radiotherapeutic perspective.
Platta CS; Mackay C; Welsh JS
Am J Clin Oncol; 2010 Aug; 33(4):408-19. PubMed ID: 19687730
[TBL] [Abstract][Full Text] [Related]
18. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
19. Incidence and familial risks in pituitary adenoma and associated tumors.
Hemminki K; Försti A; Ji J
Endocr Relat Cancer; 2007 Mar; 14(1):103-9. PubMed ID: 17395979
[TBL] [Abstract][Full Text] [Related]
20. The Epidemiology of Pituitary Adenomas.
Daly AF; Beckers A
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):347-355. PubMed ID: 32741475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
